SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.
化学名称: 5-(4'-(Dibromomethyl)(1,1'-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;
异名: Irbesartan Dibromo N2-Trityl Impurity ; Losartan Dibromo N2-Trityl Impurity ; Olmesartan Dibromo N2-Trityl Impurity ; Valsartan Dibromo N2-Trityl Impurity ; Candesartan Dibromo TTBB Impurity ;
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
微笑: BrC(Br)C(C=C1)=CC=C1C2=CC=CC=C2C3=NN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)N=N3
Candesartan Dibromo N2-Trityl Impurity is chemically 5-(4'-(Dibromomethyl)(1,1'-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;. It is also known as Irbesartan Dibromo N2-Trityl Impurity ; Losartan Dibromo N2-Trityl Impurity ; Olmesartan Dibromo N2-Trityl Impurity ; Valsartan Dibromo N2-Trityl Impurity ; Candesartan Dibromo TTBB Impurity ;. Candesartan Dibromo N2-Trityl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Candesartan Dibromo N2-Trityl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Candesartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR
Bhanu Ramana,∗, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok Kumar
Journal of Pharmaceutical and Biomedical Analysis 56 (2011) 256–263
Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors
Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang
ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369
Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets
Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan
Chromatographia volume 69, pages1211–1220(2009)
